Low-frequency electroacupuncture alleviates streptozotocin-induced neuropathic pain via noradrenaline system modulation: A combined bioelectric modeling and in vivo validation.
Jo Heejoon H, Kim Hyo-Jin HJ, Park Keun-Tae KT, Kim Hyeonah H et al.
Diabetic neuropathic pain is a common complication of diabetes with limited treatment options. Although electroacupuncture (EA) is effective for neuropathic and inflammatory pain, its mechanisms in diabetic neuropathy remain unclear. Finite element simulations compared low (2 Hz) and high (120 Hz) EA at Zusanli (ST36), modeling spatial patterns of nerve activation. Diabetic neuropathic pain was induced by 5 daily streptozotocin (STZ) injections (40 mg/kg). Behavioral assessments included measurements of mechanical and cold allodynia, body weight, and blood glucose. EA was applied at ST36 or BL20 at 2, 120, or mixed (2/120 Hz) frequencies. NA levels, α1/α2-adrenergic receptor (AR) expression, and tyrosine hydroxylase (TH)-positive neurons in the locus coeruleus (LC) were measured. Intrathecal prazosin or idazoxan was used to confirm receptor involvement. Simulations predicted broader tissue activation at 2 Hz compared to 120 Hz. In vivo, STZ caused hyperglycemia, weight loss, and mechanical allodynia without cold allodynia. EA at ST36, but not BL20, alleviated mechanical allodynia, with 2 Hz producing the strongest effect, consistent with simulation predictions. 2 Hz EA restored NA levels, rescued TH-positive LC neurons, and normalized spinal adrenergic receptor expression. These effects were abolished by prazosin or idazoxan. Combining computational modeling with experimental validation, this study shows that 2 Hz EA alleviates diabetic neuropathic pain by activating the LC-spinal NA pathway, highlighting the importance of stimulation frequency in optimizing EA therapy.